Malaysia vs Peru: HIV-positive TB patients on ART (antiretroviral therapy)
Malaysia
39.0%
in 2024
Peru
57.0%
in 2024
Malaysia rank
140th
Peru rank
137th
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Malaysia
- Peru
How they compare
Peru currently reports 57.0% against 39.0% in Malaysia, a difference of 18.0%.
That makes Peru's figure about 1.5 times Malaysia's.
The two have swapped places 3 times across 18 shared years of data; in 2007 it was Malaysia ahead.
Malaysia ranks 140th and Peru ranks 137th of 144 countries.
Across the 3 decades both report, Malaysia averaged higher in 1 and Peru in 2.
Head to head by decade
| Decade | Malaysia | Peru | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 19.1% | 12.6% | 6.5% | Malaysia |
| 2010s | 37.1% | 60.8% | 23.7% | Peru |
| 2020s | 33.2% | 53.8% | 20.6% | Peru |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Malaysia or Peru?
- Peru, at 57.0% against 39.0% in Malaysia as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Malaysia and Peru?
- 18.0%, with Peru ahead.
- How many years of comparable data are there for Malaysia and Peru?
- 18 years are reported by both, from 2007 to 2024.
- How do Malaysia and Peru rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Malaysia ranks 140th and Peru ranks 137th of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.